Literature DB >> 19833725

Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT.

Upasana Shukla1, Tomoko Hatani, Kenji Nakashima, Kazuhiro Ogi, Kiyonao Sada.   

Abstract

Adaptor protein c-Abl SH3 domain-binding protein-2 (3BP2, also referred to SH3BP2) regulates immune receptor-mediated signal transduction. In this report we focused on the molecular mechanism of 3BP2 function in B cell receptor (BCR) signaling. Engagement of BCR induces tyrosine phosphorylation of 3BP2. Genetic analysis demonstrated that Syk is critical for BCR-mediated tyrosine phosphorylation of 3BP2. Mutational analysis of 3BP2 revealed that both Tyr(183) and Src homology 2 (SH2) domain are necessary for 3BP2-mediated BCR-induced activation of nuclear factor of activated T cells (NFAT). Point mutation of Tyr(183) or Arg(486) in the SH2 domain of 3BP2 diminished BCR-mediated tyrosine phosphorylation of 3BP2. Endogenous 3BP2 forms a complex with tyrosine-phosphorylated cellular signaling molecules. Peptide binding experiments demonstrated that only phosphorylated Tyr(183) in 3BP2 could form a complex with the SH2 domain(s) of phospholipase Cgamma2 and Vav1 from B cell lysates. These interactions were represented by using bacterial glutathione S-transferase-phospholipase Cgamma2 or -Vav1 SH2 domain. Furthermore, pulldown and Far Western experiments showed that the 3BP2-SH2 domain directly binds to B cell linker protein (BLNK) after BCR stimulation. These results demonstrated that 3BP2 induces the protein complex with cellular signaling molecules through phosphorylation of Tyr(183) and SH2 domain leading to the activation of NFAT in B cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833725      PMCID: PMC2797141          DOI: 10.1074/jbc.M109.049999

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis.

Authors:  T Taniguchi; T Kobayashi; J Kondo; K Takahashi; H Nakamura; J Suzuki; K Nagai; T Yamada; S Nakamura; H Yamamura
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

2.  Identification of a ten-amino acid proline-rich SH3 binding site.

Authors:  R Ren; B J Mayer; P Cicchetti; D Baltimore
Journal:  Science       Date:  1993-02-19       Impact factor: 47.728

3.  Clustered syk tyrosine kinase domains trigger phagocytosis.

Authors:  S Greenberg; P Chang; D C Wang; R Xavier; B Seed
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

4.  Syk tyrosine kinase required for mouse viability and B-cell development.

Authors:  A M Cheng; B Rowley; W Pao; A Hayday; J B Bolen; T Pawson
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

5.  Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.

Authors:  M Turner; P J Mee; P S Costello; O Williams; A A Price; L P Duddy; M T Furlong; R L Geahlen; V L Tybulewicz
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

6.  Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.

Authors:  Z Songyang; S E Shoelson; J McGlade; P Olivier; T Pawson; X R Bustelo; M Barbacid; H Sabe; H Hanafusa; T Yi
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

7.  Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells.

Authors:  J Zhang; E H Berenstein; R L Evans; R P Siraganian
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

8.  A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2.

Authors:  M Takata; T Kurosaki
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

9.  Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function.

Authors:  A C Chan; M Dalton; R Johnson; G H Kong; T Wang; R Thoma; T Kurosaki
Journal:  EMBO J       Date:  1995-06-01       Impact factor: 11.598

10.  Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling.

Authors:  T Kurosaki; S A Johnson; L Pao; K Sada; H Yamamura; J C Cambier
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  22 in total

Review 1.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

2.  Up-regulation of Store-operated Ca2+ Entry and Nuclear Factor of Activated T Cells Promote the Acinar Phenotype of the Primary Human Salivary Gland Cells.

Authors:  Shyh-Ing Jang; Hwei Ling Ong; Xibao Liu; Ilias Alevizos; Indu S Ambudkar
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

Review 3.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

4.  3BP2 adapter protein is required for receptor activator of NFκB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells.

Authors:  Amel GuezGuez; Virginie Prod'homme; Xavier Mouska; Alice Baudot; Claudine Blin-Wakkach; Robert Rottapel; Marcel Deckert
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

5.  Dectin-1-mediated signaling leads to characteristic gene expressions and cytokine secretion via spleen tyrosine kinase (Syk) in rat mast cells.

Authors:  Yukihiro Kimura; Kazuyasu Chihara; Chisato Honjoh; Kenji Takeuchi; Shota Yamauchi; Hatsumi Yoshiki; Shigeharu Fujieda; Kiyonao Sada
Journal:  J Biol Chem       Date:  2014-09-22       Impact factor: 5.157

6.  Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors.

Authors:  Brionna Y Hair; Melissa A Troester; Sharon N Edmiston; Eloise A Parrish; Whitney R Robinson; Michael C Wu; Andrew F Olshan; Theresa Swift-Scanlan; Kathleen Conway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-12       Impact factor: 4.254

7.  Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts.

Authors:  Mizuho Kittaka; Tetsuya Yoshimoto; Collin Schlosser; Robert Rottapel; Mikihito Kajiya; Hidemi Kurihara; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2019-10-24       Impact factor: 6.741

8.  3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions.

Authors:  Noam Levaot; Paul D Simoncic; Ioannis D Dimitriou; Andrew Scotter; Jose La Rose; Adeline H M Ng; Thomas L Willett; Chiachien J Wang; Salima Janmohamed; Marc Grynpas; Ernst Reichenberger; Robert Rottapel
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

9.  The adaptor 3BP2 is required for early and late events in FcεRI signaling in human mast cells.

Authors:  Erola Ainsua-Enrich; Damiana Alvarez-Errico; Alasdair M Gilfillan; César Picado; Joan Sayós; Juan Rivera; Margarita Martín
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

10.  SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.

Authors:  Tomoyuki Mukai; Shu Ishida; Remi Ishikawa; Teruhito Yoshitaka; Mizuho Kittaka; Richard Gallant; Yi-Ling Lin; Robert Rottapel; Marco Brotto; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.